Comparative Survival Outcomes of Hyperthermic Intraperitoneal Chemotherapy, Intraperitoneal Chemotherapy and Intravenous Chemotherapy for Primary Advanced Ovarian Cancer: A Network Meta-Analysis

Objective: We aimed to compare the survival outcomes and adverse events of hyperthermic intraperitoneal chemotherapy (HIPEC), intraperitoneal chemotherapy (IP)and intravenous chemotherapy (IP)for primary advanced ovarian cancer. Methods: PubMed, CENTRAL (Cochrane Central Registry of Controlled Trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Qin, Huang, Mao, Zhang, Jing, Huang, Zhen, Wang, Linlian, Gong, Zhengxin, Tang, Liangdan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917421/
https://www.ncbi.nlm.nih.gov/pubmed/36769760
http://dx.doi.org/10.3390/jcm12031111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917421/
https://www.ncbi.nlm.nih.gov/pubmed/36769760
http://dx.doi.org/10.3390/jcm12031111

Ejemplares similares